- Author: Health Informer
- Filed under: Health News
- Date: Jul 19,2010
The FDA is warning the public that certain Advair Diskus inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used.
Advair Diskus (fluticasone propionate and salmeterol inhalation powder) is an inhaler used to treat patients with asthma and chronic obstructive pulmonary disease.
The products were reported stolen in August 2009 from a GlaxoSmithKline warehouse near Richmond, Va. The inhalers found recently were the first from the stolen lots to be found in commerce. However, more stolen product may still be on the market and the FDA continues to aggressively investigate the matter.
Stolen medicine may be harmful because it may have been stored at the wrong temperature or humidity or other improper conditions, may degrade or lose potency, become contaminated, or may have been tampered with or handled improperly while outside of the legitimate supply chain.
The lot numbers, doses, and quantities of the stolen Advair Diskus inhalers are: Read the rest of this entry »
- Author: Health Informer
- Filed under: Health News
- Date: Jul 16,2010
Too much or too little inflammation is the root of most health problems Patented i26 Hyperimmune Egg delivers a high concentration of complex immune factors needed for a balanced immune response
Imagine feeling great all the time; never feeling run down and never having to take a week off from the gym to recover from strain or injury. This isn’t a utopian vision of some far-off future – this is reality for the tens of thousands who have discovered the first and only health food that balances the body’s immune system naturally: i26 by Legacy for Life.
The $50 Million Egg And The Million Dollar Question: How Does It Work?
Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body’s once-healthy tissues. Read the rest of this entry »
- Author: Health Informer
- Filed under: Health News
- Date: Jul 15,2010
Mylan announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan’s earnings in year one, without accounting for any operational or other synergies.
Mylan Chairman and CEO Robert J. Coury said: “We are extremely pleased to be adding this complementary, high growth, high margin business to our one-of-a-kind global pharmaceutical platform. Bioniche Pharma has maintained a long-held strategy of focusing on quality injectable products with limited competition and difficult-to-develop and -manufacture compositions. With this one transaction, we will have acquired the necessary critical mass to compete in the attractive U.S. injectables market as well as the ability to even further leverage this business throughout the rest of our global commercial platform.”
In addition, Bioniche Pharma combined with UDL Laboratories, Mylan’s unit dose business, will form “Mylan Institutional,” a new hospital/institutional business in the North American region of the company’s generics segment. This business will focus on the hospital and institutional markets through which Mylan will serve group purchasing organizations, wholesalers, hospitals, surgical and radiology services, home infusion and retail areas with a differentiated and tailored product offering.
Mylan President Heather Bresch commented: “This acquisition satisfies one of our long-standing objectives of filling product and therapeutic gaps in our U.S. portfolio. Bioniche Pharma injectables and Mylan’s U.S. offerings – including Mylan Pharmaceuticals’ extensive solid-dose portfolio; Mylan Technologies’ innovative transdermal technologies, such as Fentanyl Transdermal System; and UDL Laboratories’ well-established distribution channel – are expected to position Mylan as a leader in the U.S. institutional marketplace.” Read the rest of this entry »
Leading Pediatricians Provide Solutions to Help Moms Experience the Joy of Healthy Feeding
For a majority of first-time moms feeding their baby can be an emotional and stressful experience. New moms encountering these common, yet unexpected feeding challenges are not alone. A recent national survey, commissioned by Playtex®, revealed that 85 percent of first-time moms have experienced at least one feeding-related problem when caring for their new baby.(1)
As a leader in infant care, Playtex commissioned this national survey to better understand common issues, anxieties and concerns first-time moms face when feeding their babies. To further address the survey findings, Playtex brought together leading pediatricians Drs. William Sears, Alanna Levine and Laura Jana today for a Web symposium. The goal of this expert forum was to provide meaningful insights and solutions to help moms experience the joy of healthy feeding. Read the rest of this entry »